LT2502622T - Farmacinė vaisto forma, apimanti inozitolį - Google Patents

Farmacinė vaisto forma, apimanti inozitolį

Info

Publication number
LT2502622T
LT2502622T LTEP12160674.3T LT12160674T LT2502622T LT 2502622 T LT2502622 T LT 2502622T LT 12160674 T LT12160674 T LT 12160674T LT 2502622 T LT2502622 T LT 2502622T
Authority
LT
Lithuania
Prior art keywords
form including
pharmaceutical form
including inositol
inositol
pharmaceutical
Prior art date
Application number
LTEP12160674.3T
Other languages
English (en)
Inventor
Vittorio Unfer
Original Assignee
Lo. Li. Pharma S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lo. Li. Pharma S.R.L. filed Critical Lo. Li. Pharma S.R.L.
Publication of LT2502622T publication Critical patent/LT2502622T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP12160674.3T 2011-03-22 2012-03-22 Farmacinė vaisto forma, apimanti inozitolį LT2502622T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000445A ITMI20110445A1 (it) 2011-03-22 2011-03-22 Formulazione farmaceutica comprendente inositolo.

Publications (1)

Publication Number Publication Date
LT2502622T true LT2502622T (lt) 2020-07-27

Family

ID=43977111

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP16202982.1T LT3178474T (lt) 2011-03-22 2012-03-22 Farmacinė vaisto forma, apimanti inozitolį
LTEP12160674.3T LT2502622T (lt) 2011-03-22 2012-03-22 Farmacinė vaisto forma, apimanti inozitolį

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP16202982.1T LT3178474T (lt) 2011-03-22 2012-03-22 Farmacinė vaisto forma, apimanti inozitolį

Country Status (23)

Country Link
US (1) US20140010870A1 (lt)
EP (2) EP3178474B1 (lt)
CL (1) CL2013002700A1 (lt)
CY (2) CY1122980T1 (lt)
DK (2) DK2502622T3 (lt)
EA (1) EA026746B1 (lt)
ES (2) ES2798267T3 (lt)
HR (2) HRP20200792T1 (lt)
HU (2) HUE051001T2 (lt)
IL (1) IL228465B (lt)
IT (1) ITMI20110445A1 (lt)
LT (2) LT3178474T (lt)
MA (1) MA35043B1 (lt)
ME (1) ME03750B (lt)
MX (1) MX2013010812A (lt)
PE (1) PE20141011A1 (lt)
PL (2) PL3178474T3 (lt)
PT (2) PT2502622T (lt)
RS (2) RS60650B1 (lt)
SM (2) SMT202000288T1 (lt)
TN (1) TN2013000373A1 (lt)
UA (1) UA115425C2 (lt)
WO (1) WO2012126931A1 (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
JP6838146B2 (ja) * 2016-10-06 2021-03-03 ディーワイ ナチュラル カンパニー リミテッド ピニトール、ｄ−カイロ−イノシトール、又はこれらの類似化合物を有効成分として含む、女性の更年期症状の改善、予防、又は治療用の組成物
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
BR112020010343A2 (pt) * 2017-11-23 2020-11-10 Biosearch, S.A. método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico
US20210236528A1 (en) * 2018-08-22 2021-08-05 Societe Des Produits Nestle S.A. Composition comprising isomers of inositol and its use
JP2022546267A (ja) * 2019-08-30 2022-11-04 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ｓｃｙｌｌｏ－イノシトール及びβ細胞介在性疾患
CN115484939A (zh) * 2019-09-24 2022-12-16 雀巢产品有限公司 鲨肌醇及其作为胰岛素敏化剂的用途
RU2757220C1 (ru) * 2020-06-03 2021-10-12 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Фармацевтическая композиция для профилактики и лечения синдрома поликистозных яичников
RU2771426C1 (ru) * 2021-05-03 2022-05-04 Румиса Рамзановна Бериханова Способ коррекции дислипидемии у женщин с метаболическим синдромом в периоде менопаузального перехода
IT202300017805A1 (it) * 2023-08-30 2025-03-02 Idi Integratori Dietetici Italiani S R L Nuova composizione comprendente teupolioside e inositolo
WO2025254861A1 (en) * 2024-06-04 2025-12-11 Eirgen Pharma, Ltd. A combination of scyllo-inositol and n-acetyl cysteine and related compounds
WO2026013420A1 (en) 2024-07-10 2026-01-15 Ioulia Tseti Compositions for supporting women with gynaecological syndromes
GR1011145B (el) * 2025-03-24 2026-03-04 Ιουλια Τσετη Συνθεση μυοϊνοσιτολης για υποστηριξη γυναικων με συνδρομο πολυκυστικων ωοθηκων υπο μορφη μονοδοσικου ποσιμου διαλυματος

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
CA2047686C (en) * 1989-03-08 2000-09-05 Joseph Larner Dietary supplement for insulin-resistant diabetics
TW282398B (lt) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
CA2371055A1 (en) * 1999-04-27 2000-11-02 Insmed Pharmaceuticals, Inc. Compositions and methods for improving insulin sensitivity and glucose metabolism in mammals
US6992065B2 (en) * 2000-04-19 2006-01-31 Genentech, Inc. Sustained release formulations
AU2005265617B2 (en) * 2004-07-30 2010-09-30 Wakunaga Pharmaceutical Co., Ltd. Composition for capsule film, capsule film, and capsule made with the same
WO2007004523A1 (ja) * 2005-07-04 2007-01-11 Tokyo Medical And Dental University Ｌ－アルギニン含有医薬組成物及び飲食品用組成物
CA2637806A1 (en) * 2005-11-07 2007-05-18 Russell M. Jaffe Compositions for regulating metabolic disorders and methods of use thereof
US20070104801A1 (en) * 2005-11-07 2007-05-10 Ivf Online Llc Fertility and anti-aging supplement for the fertility health of females and males
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
US20120232003A1 (en) * 2009-03-13 2012-09-13 Takahashi Joseph S Compositions and methods for diabetes treatment
SI2542224T1 (sl) * 2010-03-01 2014-10-30 Ratiopharm Gmbh Oralni farmacevtski sestavek, ki vsebuje dabigatran eteksilat

Also Published As

Publication number Publication date
EP2502622A1 (en) 2012-09-26
WO2012126931A1 (en) 2012-09-27
TN2013000373A1 (en) 2015-01-20
IL228465B (en) 2018-01-31
EA201301061A1 (ru) 2014-02-28
ES2806937T3 (es) 2021-02-19
PE20141011A1 (es) 2014-08-27
US20140010870A1 (en) 2014-01-09
CL2013002700A1 (es) 2014-07-11
SMT202000364T1 (it) 2020-09-10
DK2502622T3 (da) 2020-09-07
MX2013010812A (es) 2014-03-21
EP3178474B1 (en) 2020-03-18
PL2502622T3 (pl) 2020-11-16
HRP20201048T1 (hr) 2020-10-16
PL3178474T3 (pl) 2020-09-21
PT2502622T (pt) 2020-06-29
LT3178474T (lt) 2020-05-11
RS60377B1 (sr) 2020-07-31
CY1123134T1 (el) 2021-10-29
SMT202000288T1 (it) 2020-07-08
EP2502622B1 (en) 2020-06-10
ME03750B (me) 2021-04-20
RS60650B1 (sr) 2020-09-30
DK3178474T3 (da) 2020-06-08
IL228465A0 (en) 2013-12-31
PT3178474T (pt) 2020-05-06
UA115425C2 (uk) 2017-11-10
ITMI20110445A1 (it) 2012-09-23
CY1122980T1 (el) 2021-10-29
HRP20200792T1 (hr) 2020-07-24
EA026746B1 (ru) 2017-05-31
MA35043B1 (fr) 2014-04-03
HUE051001T2 (hu) 2021-01-28
ES2798267T3 (es) 2020-12-10
HUE049942T2 (hu) 2020-11-30
EP3178474A1 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
SMT201600476B (it) Tenofovir alafenammide emifumarato
EP2709645A4 (en) ENHANCED PEPTIDE PHARMACEUTICAL AGENTS
BR112014002399A2 (pt) conjunto
LT2502622T (lt) Farmacinė vaisto forma, apimanti inozitolį
DE102011100082A8 (de) Traygreifvorrichtung
UY4109Q (es) Calzado
EP2752374A4 (en) gooseneck
BR112013032352A2 (pt) doença tromboembólica
CO6870021A2 (es) Conjunto dispensador
BR112014000879A2 (pt) deflegmador
BR112014009319A2 (pt) compostos farmacêuticos
BR112014015885A8 (pt) preparação farmacêutica
IL231660A0 (en) Composition
HRP20181667T1 (hr) Pripravak
FIU20114055U0 (fi) Välipohja
DK2476953T3 (da) Fluidbedkedel
EP2747907A4 (en) SINKING PANEL OF ORES
EP2694655A4 (en) pAVEC
FI10522U1 (fi) Sihti
UA22259S (uk) Нашивка
FI20115375A0 (fi) Uudet hypoallergeenit
ES1074622Y (es) Pilona mejorada
ES1074509Y (es) Calzado
ITPD20110017U1 (it) Calzatura
UY4122Q (es) Calzado